Open Calls

EU4Health

Procurement:

Speed up the Development of and Access to Innovative Medical Countermeasures. HADEA/2023/OP/0036 (Total estimated value €82.0 million, deadline 4 December 2023):

  • Lot 1 Vaccines to combat antimicrobial resistance (est. €22.0 million)
  • Lot 2 Broad spectrum antivirals against respiratory diseases (est. €18.0 million)
  • Lot 3 Broad spectrum antivirals targeting viral families known for causing Viral Haemorrhagic Fever (VHF) (est. €18.0 million.
  • Lot 4 Point of Care metagenomic sequencing for universal pathogen detection (est. €24.0 million).

Upcoming Calls

EU4Health

Procurement:

  • Study on the Quality of Life of Cancer Patients and Survivors. HADEA/2023/OP/0038-PIN  (Est. value €1.5 million).
  • Building Capacity and Knowledge for the Implementation of the EU Health Technology Assessment Regulation. HADEA/2023/OP/0032-PIN  (Est. value €1.0 million)

Tenders are expected across 2023 in the areas of crisis preparedness, health promotion & disease prevention, cancer, health systems & healthcare workforce and digital.

The indicative budget is €24.5 million.

 

Horizon Europe Health Cluster

The Health Cluster Work Programme for 2023/ 2024 is published and available to download.

Health Cluster 2024 Single Stage call topics are open and will close on 11 April 2024.

Call topics are divided into Destinations and include:

Destination 3. Tackling diseases and reducing disease burden.

HORIZON-HLTH-2024-DISEASE-08-12: Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness 

HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential

Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society.

HORIZON-HLTH-2024-TOOL-11-02: Bio-printing of living cells for regenerative medicine

Destination 6. Maintaining an innovative, sustainable and globally competitive health industry.

HORIZON-HLTH-2024-IND-06-08: Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) 

HORIZON-HLTH-2024-IND-06-09: Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators.

Upcoming Calls

Cancer Mission 2024

Cancer mission 2024 work programme is under development and calls will open in April 2024.

For further details, please contact Health NCP Irene Castellano (email: ICastellano@hrb.ie)